The participation of people deprived of liberty in tuberculosis vaccine trials: should they be protected from research, or through research?
Saved in:
| Title: | The participation of people deprived of liberty in tuberculosis vaccine trials: should they be protected from research, or through research? |
|---|---|
| Authors: | Andrews JR; Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA., Charalambous S; The Aurum Institute, Johannesburg, South Africa; School of Public Health, University of Witwatersrand, Johannesburg, South Africa; Department of Medicine, Vanderbilt University, Nashville, TN, USA., Churchyard G; The Aurum Institute, Johannesburg, South Africa; School of Public Health, University of Witwatersrand, Johannesburg, South Africa; Department of Medicine, Vanderbilt University, Nashville, TN, USA., Cobelens F; Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., Fernández-Escobar C; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain., Frick M; Tuberculosis Project, Treatment Action Group, New York, NY, USA., Hanekom W; Division of Infection and Immunity, University College London, London, UK; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa., Hatherill M; Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Hill PC; Center for International Health, University of Otago, Dunedin, New Zealand., Pandey S; BL Pandey Foundation for Social Initiatives, Delhi, India., Rangaka MX; MRC Clinical Trials Unit, University College London, London, UK; CIDRI-AFRICA, School of Public Health, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., White RG; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Lemos EF; Prison Community Advisory Board, Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, Brazil; State University of Mato Grosso do Sul, Campo Grande, Brazil., da Silva AM; Prison Community Advisory Board, Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, Brazil., Croda J; Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil; Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, Brazil; Yale University School of Public Health, New Haven, CT, USA. Electronic address: julio.croda@fiocruz.br., Garcia-Basteiro AL; Centro de Investigação em Saúde de Manhiça, Manhiça, Mozambique; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Barcelona, Spain; Department of Preventive Medicine and Epidemiology, Hospital Clínic Barcelona, Barcelona, Spain. |
| Source: | The Lancet. Infectious diseases [Lancet Infect Dis] 2025 Dec; Vol. 25 (12), pp. e722-e729. Date of Electronic Publication: 2025 Jun 27. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40587989 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The participation of people deprived of liberty in tuberculosis vaccine trials: should they be protected from research, or through research? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Andrews+JR%22">Andrews JR</searchLink>; Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Charalambous+S%22">Charalambous S</searchLink>; The Aurum Institute, Johannesburg, South Africa; School of Public Health, University of Witwatersrand, Johannesburg, South Africa; Department of Medicine, Vanderbilt University, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Churchyard+G%22">Churchyard G</searchLink>; The Aurum Institute, Johannesburg, South Africa; School of Public Health, University of Witwatersrand, Johannesburg, South Africa; Department of Medicine, Vanderbilt University, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Cobelens+F%22">Cobelens F</searchLink>; Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Fernández-Escobar+C%22">Fernández-Escobar C</searchLink>; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Frick+M%22">Frick M</searchLink>; Tuberculosis Project, Treatment Action Group, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Hanekom+W%22">Hanekom W</searchLink>; Division of Infection and Immunity, University College London, London, UK; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa.<br /><searchLink fieldCode="AU" term="%22Hatherill+M%22">Hatherill M</searchLink>; Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Hill+PC%22">Hill PC</searchLink>; Center for International Health, University of Otago, Dunedin, New Zealand.<br /><searchLink fieldCode="AU" term="%22Pandey+S%22">Pandey S</searchLink>; BL Pandey Foundation for Social Initiatives, Delhi, India.<br /><searchLink fieldCode="AU" term="%22Rangaka+MX%22">Rangaka MX</searchLink>; MRC Clinical Trials Unit, University College London, London, UK; CIDRI-AFRICA, School of Public Health, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22White+RG%22">White RG</searchLink>; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Lemos+EF%22">Lemos EF</searchLink>; Prison Community Advisory Board, Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, Brazil; State University of Mato Grosso do Sul, Campo Grande, Brazil.<br /><searchLink fieldCode="AU" term="%22da+Silva+AM%22">da Silva AM</searchLink>; Prison Community Advisory Board, Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, Brazil.<br /><searchLink fieldCode="AU" term="%22Croda+J%22">Croda J</searchLink>; Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil; Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, Brazil; Yale University School of Public Health, New Haven, CT, USA. Electronic address: julio.croda@fiocruz.br.<br /><searchLink fieldCode="AU" term="%22Garcia-Basteiro+AL%22">Garcia-Basteiro AL</searchLink>; Centro de Investigação em Saúde de Manhiça, Manhiça, Mozambique; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Barcelona, Spain; Department of Preventive Medicine and Epidemiology, Hospital Clínic Barcelona, Barcelona, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101130150%22">The Lancet. Infectious diseases</searchLink> [Lancet Infect Dis] 2025 Dec; Vol. 25 (12), pp. e722-e729. <i>Date of Electronic Publication: </i>2025 Jun 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101130150 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-4457 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214733099%22">14733099 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40587989 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S1473-3099(25)00305-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e722 Titles: – TitleFull: The participation of people deprived of liberty in tuberculosis vaccine trials: should they be protected from research, or through research? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Andrews JR – PersonEntity: Name: NameFull: Charalambous S – PersonEntity: Name: NameFull: Churchyard G – PersonEntity: Name: NameFull: Cobelens F – PersonEntity: Name: NameFull: Fernández-Escobar C – PersonEntity: Name: NameFull: Frick M – PersonEntity: Name: NameFull: Hanekom W – PersonEntity: Name: NameFull: Hatherill M – PersonEntity: Name: NameFull: Hill PC – PersonEntity: Name: NameFull: Pandey S – PersonEntity: Name: NameFull: Rangaka MX – PersonEntity: Name: NameFull: White RG – PersonEntity: Name: NameFull: Lemos EF – PersonEntity: Name: NameFull: da Silva AM – PersonEntity: Name: NameFull: Croda J – PersonEntity: Name: NameFull: Garcia-Basteiro AL IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2025 Dec Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1474-4457 Numbering: – Type: volume Value: 25 – Type: issue Value: 12 Titles: – TitleFull: The Lancet. Infectious diseases Type: main |
| ResultId | 1 |